$ALT
Altimmune, Inc. Stock $alt

$alt Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-K Financial Statement

#000114420413014894 Filed on March 14, 2013

Income Statement

Concept	2013 Q1	2012	2011 Q4
Revenue	$6.480M	$25.18M	$6.240M
YoY Change	5.37%	3.75%	-8.91%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.280M	$11.63M	$2.680M
YoY Change	-22.71%	-18.73%	-50.28%
% of Gross Profit
Research & Development	$5.233M	$19.51M	$4.530M
YoY Change	11.22%	-8.06%	18.9%
% of Gross Profit
Depreciation & Amortization	$52.60K	$303.9K	$110.0K
YoY Change	-41.55%	-34.09%	-57.69%
% of Gross Profit
Operating Expenses	$7.566M	$31.44M	$7.320M
YoY Change	-2.25%	-12.64%	-48.09%
Operating Profit	-$1.091M	-$6.266M	-$1.083M
YoY Change	-31.43%	-46.56%
Interest Expense	$99.79K	$324.8K	$1.060M
YoY Change	3195.61%	495.08%	-111.84%
% of Operating Profit
Other Income/Expense, Net	-$1.011M	$1.542M	-$10.00K
YoY Change	7.68%	-80.55%	-150.0%
Pretax Income	-$2.102M	-$4.725M	$750.0K
YoY Change	-16.91%	24.41%	-104.64%
Income Tax	$9.743K	$195.5K	$0.00
% Of Pretax Income			0.0%
Net Earnings	-$2.111M	-$4.920M	$749.2K
YoY Change	-21.21%	29.56%	-104.63%
Net Earnings / Revenue	-32.58%	-19.54%	12.01%
Basic Earnings Per Share	-$0.04		$0.02
Diluted Earnings Per Share	-$0.04	-$30.75M	$0.02
COMMON SHARES
Basic Shares Outstanding	48.37M
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q1	2012	2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.90M	$12.70M	$11.20M
YoY Change	-15.69%	13.39%	-5.08%
Cash & Equivalents	$12.87M	$12.70M	$11.24M
Short-Term Investments
Other Short-Term Assets	$600.0K	$500.0K	$900.0K
YoY Change	-25.0%	-44.44%	-64.0%
Inventory
Prepaid Expenses
Receivables	$5.600M	$6.500M	$7.400M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$19.07M	$19.80M	$19.61M
YoY Change	-11.43%	1.02%	-16.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$456.8K	$500.0K	$788.7K
YoY Change	-34.92%	-37.5%	-34.28%
Goodwill	$2.348M		$2.348M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$99.58K	$100.0K	$53.38K
YoY Change	-42.94%	0.0%	-46.62%
Total Long-Term Assets	$2.905M	$2.900M	$3.191M
YoY Change	-9.93%	-9.38%	-11.37%
TOTAL ASSETS
Total Short-Term Assets	$19.07M	$19.80M	$19.61M
Total Long-Term Assets	$2.905M	$2.900M	$3.191M
Total Assets	$21.97M	$22.70M	$22.80M
YoY Change	-11.24%	-0.44%	-16.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.290M	$1.700M	$1.446M
YoY Change	-8.57%	21.43%	-53.36%
Accrued Expenses	$3.300M	$2.300M	$2.700M
YoY Change	13.79%	-14.81%	-10.0%
Deferred Revenue
YoY Change
Short-Term Debt	$1.329M	$1.300M
YoY Change	54.96%
Long-Term Debt Due	$1.000M	$800.0K
YoY Change	411.74%
Total Short-Term Liabilities	$7.788M	$7.500M	$4.615M
YoY Change	46.55%	63.04%	-25.56%
LONG-TERM LIABILITIES
Long-Term Debt	$1.460M	$1.700M
YoY Change	-34.65%
Other Long-Term Liabilities	$580.2K	$1.900M	$449.7K
YoY Change	4.36%	-17.39%	-94.89%
Total Long-Term Liabilities	$2.041M	$3.600M	$449.7K
YoY Change	-26.88%	56.52%	-94.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.788M	$7.500M	$4.615M
Total Long-Term Liabilities	$2.041M	$3.600M	$449.7K
Total Liabilities	$12.03M	$11.10M	$6.952M
YoY Change	9.53%	58.57%	-53.66%
SHAREHOLDERS EQUITY
Retained Earnings	-$200.7M		-$193.7M
YoY Change	2.22%
Common Stock	$210.9M		$208.5M
YoY Change	0.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.943M	$11.70M	$15.85M
YoY Change
Total Liabilities & Shareholders Equity	$21.97M	$22.70M	$22.80M
YoY Change	-11.24%	-0.44%	-16.16%

Cashflow Statement

Concept	2013 Q1	2012	2011 Q4
OPERATING ACTIVITIES
Net Income	-$2.111M	-$4.920M	$749.2K
YoY Change	-21.21%	29.56%	-104.63%
Depreciation, Depletion And Amortization	$52.60K	$303.9K	$110.0K
YoY Change	-41.55%	-34.09%	-57.69%
Cash From Operating Activities	$260.4K	-$2.323M	-$810.0K
YoY Change	-67.09%	-70.25%	-87.93%
INVESTING ACTIVITIES
Capital Expenditures	$25.47K		$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$70.00K	$1.760M
YoY Change	-100.0%	-96.02%
Cash From Investing Activities	-$25.47K	$67.40K	$1.760M
YoY Change	-137.79%	-96.01%	-3620.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$53.41K	$38.98K
YoY Change		-99.33%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$60.36K	$3.720M	30.00K
YoY Change	-101.88%	-35.65%	-99.81%
NET CHANGE
Cash From Operating Activities	$260.4K	-$2.323M	-810.0K
Cash From Investing Activities	-$25.47K	$67.40K	1.760M
Cash From Financing Activities	-$60.36K	$3.720M	30.00K
Net Change In Cash	$174.6K	$1.465M	980.0K
YoY Change	-95.7%	-531.13%	-89.25%
FREE CASH FLOW
Cash From Operating Activities	$260.4K	-$2.323M	-$810.0K
Capital Expenditures	$25.47K		$0.00
Free Cash Flow	$234.9K	-$2.323M	-$810.0K
YoY Change	-70.31%	-70.52%	-87.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012	dei	Amendment Flag AmendmentFlag	false
CY2012	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2012	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2012	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
CY2012	dei	Document Period End Date DocumentPeriodEndDate	2012-12-31
CY2012	dei	Document Type DocumentType	10-K
CY2012	dei	Entity Central Index Key EntityCentralIndexKey	0001326190
CY2013Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48365984
CY2012	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2012	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2012Q2	dei	Entity Public Float EntityPublicFloat	56300000	USD
CY2012	dei	Entity Registrant Name EntityRegistrantName	PHARMATHENE, INC
CY2012	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2012	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2012	dei	Trading Symbol TradingSymbol	PIP
CY2011Q4	pip	Accounts Receivable Reclassified As Prepaid Expense And Other Assets Current AccountsReceivableReclassifiedAsPrepaidExpenseAndOtherAssetsCurrent	500000	USD
CY2010Q4	pip	Accounts Receivable Reclassified As Prepaid Expense And Other Assets Current AccountsReceivableReclassifiedAsPrepaidExpenseAndOtherAssetsCurrent	600000	USD
CY2011Q4	pip	Accrued Development Expenses AccruedDevelopmentExpenses	1479105	USD
CY2012Q4	pip	Accrued Development Expenses AccruedDevelopmentExpenses	1716557	USD
CY2011Q4	pip	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	2655330	USD
CY2012Q4	pip	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	2328877	USD
CY2011Q4	pip	Deferred Tax Assets Net Before Valuation Allowance DeferredTaxAssetsNetBeforeValuationAllowance	63984247	USD
CY2012Q4	pip	Deferred Tax Assets Net Before Valuation Allowance DeferredTaxAssetsNetBeforeValuationAllowance	63586299	USD
CY2011	pip	Income Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance	-14138691	USD
CY2010	pip	Income Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance	-1597604	USD
CY2012	pip	Income Tax Expense Benefit Before Change In Valuation Allowance IncomeTaxExpenseBenefitBeforeChangeInValuationAllowance	397948	USD
CY2011	pip	Lobbying Costs LobbyingCosts		USD
CY2010	pip	Lobbying Costs LobbyingCosts		USD
CY2012	pip	Lobbying Costs LobbyingCosts	122204	USD
CY2011	pip	Other Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation		USD
CY2010	pip	Other Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation		USD
CY2012	pip	Other Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation OtherIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation	-1227656	USD
CY2011	pip	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	5855689	USD
CY2010	pip	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	21601075	USD
CY2012	pip	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	38984	USD
CY2011	pip	Proceeds From Issuance Of Long Term Debt And Warrants ProceedsFromIssuanceOfLongTermDebtAndWarrants		USD
CY2010	pip	Proceeds From Issuance Of Long Term Debt And Warrants ProceedsFromIssuanceOfLongTermDebtAndWarrants	-11439	USD
CY2012	pip	Proceeds From Issuance Of Long Term Debt And Warrants ProceedsFromIssuanceOfLongTermDebtAndWarrants	2500000	USD
CY2011	pip	Proceeds From Sale Of Assets Held For Sale ProceedsFromSaleOfAssetsHeldForSale	1758960	USD
CY2010	pip	Proceeds From Sale Of Assets Held For Sale ProceedsFromSaleOfAssetsHeldForSale		USD
CY2012	pip	Proceeds From Sale Of Assets Held For Sale ProceedsFromSaleOfAssetsHeldForSale		USD
CY2011	pip	Provision And Recovery For Doubtful Accounts ProvisionAndRecoveryForDoubtfulAccounts	-40524	USD
CY2010	pip	Provision And Recovery For Doubtful Accounts ProvisionAndRecoveryForDoubtfulAccounts	2935063	USD
CY2012	pip	Provision And Recovery For Doubtful Accounts ProvisionAndRecoveryForDoubtfulAccounts		USD
CY2012	pip	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Annual Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate	0.12
CY2010	pip	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	2699	USD
CY2009Q3	pip	Stock Issued Value Convertible Notes And Stock Purchase Warrants StockIssuedValueConvertibleNotesAndStockPurchaseWarrants	19300000	USD
CY2012	pip	Stock Purchase Warrants Issued In Connection With Issuance Of Long Term Debt StockPurchaseWarrantsIssuedInConnectionWithIssuanceOfLongTermDebt	69876	USD
CY2011	pip	Supplemental Warrant Issued In Connection With Long Term Debt SupplementalWarrantIssuedInConnectionWithLongTermDebt		USD
CY2010	pip	Supplemental Warrant Issued In Connection With Long Term Debt SupplementalWarrantIssuedInConnectionWithLongTermDebt		USD
CY2012	pip	Supplemental Warrant Issued In Connection With Long Term Debt SupplementalWarrantIssuedInConnectionWithLongTermDebt	69876	USD
CY2010	pip	Therapeutic Discovery Tax Grants Offset Against Research And Development Expense TherapeuticDiscoveryTaxGrantsOffsetAgainstResearchAndDevelopmentExpense	900000	USD
CY2011	pip	Value Of Warrants Issued In Connection With Issuance Of Common Stock ValueOfWarrantsIssuedInConnectionWithIssuanceOfCommonStock	668640	USD
CY2010	pip	Value Of Warrants Issued In Connection With Issuance Of Common Stock ValueOfWarrantsIssuedInConnectionWithIssuanceOfCommonStock	2070146	USD
CY2012	pip	Value Of Warrants Issued In Connection With Issuance Of Common Stock ValueOfWarrantsIssuedInConnectionWithIssuanceOfCommonStock		USD
CY2009Q3	pip	Warrant Expiration Date WarrantExpirationDate	2015-01-28
CY2010Q2	pip	Warrant Expiration Date WarrantExpirationDate	2015-10-13
CY2010Q3	pip	Warrant Expiration Date WarrantExpirationDate	2017-01-23
CY2011Q2	pip	Warrant Expiration Date WarrantExpirationDate	2016-06-15
CY2010Q4	pip	Warrants Outstanding Not Exercisable WarrantsOutstandingNotExercisable	1323214
CY2012	pip	Weighted Average Volatility Calculation WeightedAverageVolatilityCalculation	0.5
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1445700	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1697280	USD
CY2011Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	752469	USD
CY2012Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	189746	USD
CY2011Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	423756	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	365680	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1613058	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1905180	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	1010522	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-217328	USD
CY2011Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	208525917	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	210495905	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2251501	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2292479	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1803427	USD
CY2010Q4	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	400000	USD
CY2010Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	140000	USD
CY2010Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	145000	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2565961	USD
CY2010	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2513159	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1894099	USD
CY2011	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12000000
CY2010	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10700000
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11900000
CY2010	us-gaap	Asset Impairment Charges AssetImpairmentCharges	3800000	USD
CY2011Q4	us-gaap	Assets Assets	22803509	USD
CY2012Q4	us-gaap	Assets Assets	22741404	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	19613006	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	19795845	USD
CY2010Q4	us-gaap	Assets Held For Sale Property Plant And Equipment AssetsHeldForSalePropertyPlantAndEquipment	1000000	USD
CY2011Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	4424442	USD
CY2012Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	2432641	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11236771	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11785327	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2673567	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12701517	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-548556	USD
CY2010	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	9111760	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1464746	USD
CY2010Q2	us-gaap	Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable	2010-10-13
CY2010Q3	us-gaap	Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable	2011-01-23
CY2010Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	1.89
CY2010Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	1.63
CY2011Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	3.5
CY2011Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5573544
CY2010Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5202121
CY2012Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5620128
CY2010Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	500000
CY2010Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1323214
CY2011Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	371423
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48236172
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48352651
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48236172
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48352651
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	4824	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	4835	USD
CY2012	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Concentration of Credit Risk</em></strong></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Financial instruments that potentially subject us to concentrations of credit risk are primarily cash, restricted cash and cash equivalents, and billed and unbilled accounts receivable.  We maintain our cash, restricted cash and cash equivalents in the form of money market accounts and overnight deposits with financial institutions that we believe are credit worthy. Because our billed and unbilled accounts receivable consist of amounts due from the U.S. federal government, management deems there to be minimal credit risk.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><em> </em></strong></p> <!--EndFragment--></div> </div>
CY2011	us-gaap	Contracts Revenue ContractsRevenue	24266274	USD
CY2010	us-gaap	Contracts Revenue ContractsRevenue	20993605	USD
CY2012	us-gaap	Contracts Revenue ContractsRevenue	25175887	USD
CY2012Q1	us-gaap	Contracts Revenue ContractsRevenue	6149052	USD
CY2012Q2	us-gaap	Contracts Revenue ContractsRevenue	6316998	USD
CY2012Q3	us-gaap	Contracts Revenue ContractsRevenue	6696126	USD
CY2012Q4	us-gaap	Contracts Revenue ContractsRevenue	6013711	USD
CY2011Q1	us-gaap	Contracts Revenue ContractsRevenue	6337722	USD
CY2011Q2	us-gaap	Contracts Revenue ContractsRevenue	6428840	USD
CY2011Q3	us-gaap	Contracts Revenue ContractsRevenue	5260057	USD
CY2011Q4	us-gaap	Contracts Revenue ContractsRevenue	6239655	USD
CY2010Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	11000	USD
CY2011	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	700000	USD
CY2010	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	2900000	USD
CY2012	us-gaap	Cost Of Reimbursable Expense CostOfReimbursableExpense	1100000	USD
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		USD
CY2010	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	195529	USD
CY2012Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2500000	USD
CY2010Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	2.54
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		USD
CY2010	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	195529	USD
CY2011Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6209959	USD
CY2012Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3978944	USD
CY2011Q4	us-gaap	Deferred Revenue DeferredRevenue	514312	USD
CY2012Q4	us-gaap	Deferred Revenue DeferredRevenue	1381755	USD
CY2011Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	70194206	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	67565243	USD
CY2011Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-195497	USD
CY2011Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	62873360	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	58334073	USD
CY2011Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	49389	USD
CY2012Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	114826	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3291651	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3278995	USD
CY2011Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.0
CY2011Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2010	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.08
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.1
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2011Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2611770	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3047573	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1368036	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2789776	USD
CY2011Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	63984247	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	63781796	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	6209959	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3978944	USD
CY2011	us-gaap	Depreciation And Amortization DepreciationAndAmortization	461073	USD
CY2010	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1020376	USD
CY2012	us-gaap	Depreciation And Amortization DepreciationAndAmortization	303916	USD
CY2012Q4	us-gaap	Derivative Financial Instruments Liabilities Fair Value Disclosure DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure	1295613	USD
CY2011Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1886652	USD
CY2012Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1295613	USD
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.0
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2011Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2011Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.0
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2011Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2011Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2011Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.0
CY2011Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2011	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-208852	USD
CY2010	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-240122	USD
CY2012	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	181	USD
CY2012Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2300000	USD
CY2012	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y4M10D
CY2011	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-100000	USD
CY2010	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	100000	USD
CY2012	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-10000	USD
CY2011	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	781760	USD
CY2010	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		USD
CY2012	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		USD
CY2011	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		USD
CY2010	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		USD
CY2012	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	66626	USD
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14311079	USD
CY2010	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18015761	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11628732	USD
CY2011Q4	us-gaap	Goodwill Goodwill	2348453	USD
CY2012Q4	us-gaap	Goodwill Goodwill	2348453	USD
CY2011	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	14138691	USD
CY2010	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1597604	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-202451	USD
CY2011	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate		USD
CY2010	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate		USD
CY2012	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	388656	USD
CY2011	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther	-391826	USD
CY2012	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	1093234	USD
CY2010Q4	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	1100000	USD
CY2011	us-gaap	Interest Expense InterestExpense	54573	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2010	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	195497	USD
CY2010	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	800000	USD
CY2010	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	4635489	USD
CY2011	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf		USD
CY2010	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	4635489	USD
CY2012	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf		USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3797573	USD
CY2010	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-34849277	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4724586	USD
CY2011	us-gaap	Income Taxes Paid IncomeTaxesPaid	10630	USD
CY2010	us-gaap	Income Taxes Paid IncomeTaxesPaid		USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid		USD
CY2012	us-gaap	Interest Paid InterestPaid	220219	USD
CY2010	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther	-3071189	USD
CY2012	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther	-193605	USD
CY2011	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-50173	USD
CY2010	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	2492478	USD
CY2012	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-80292	USD
CY2011	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1291175	USD
CY2010	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-11848754	USD
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1604648	USD
CY2011	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-4745271	USD
CY2010	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	5053927	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther		USD
CY2011	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	22101	USD
CY2010	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	607981	USD
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	4975	USD
CY2011	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	732322	USD
CY2010	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	309840	USD
CY2012	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	1393366	USD
CY2011	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-232489	USD
CY2010	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1284265	USD
CY2012	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-19918	USD
CY2011	us-gaap	Income Tax Reconciliation Tax Settlements Foreign IncomeTaxReconciliationTaxSettlementsForeign	-8965832	USD
CY2010	us-gaap	Income Tax Reconciliation Tax Settlements Foreign IncomeTaxReconciliationTaxSettlementsForeign		USD
CY2012	us-gaap	Income Tax Reconciliation Tax Settlements Foreign IncomeTaxReconciliationTaxSettlementsForeign		USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1682461	USD
CY2010	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1245975	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	251561	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-20748	USD
CY2010	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1279875	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1991801	USD
CY2011	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-391904	USD
CY2010	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-8513914	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-418076	USD
CY2011	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	514312	USD
CY2010	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	867443	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1481150	USD
CY2010	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	650722	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-367149	USD
CY2011	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-987408	USD
CY2010	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	-5408216	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	800000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	6951703	USD
CY2012Q4	us-gaap	Liabilities Liabilities	11067564	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22803509	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22741404	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4615342	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7488416	USD
CY2010	us-gaap	Interest Expense InterestExpense	5936480	USD
CY2012	us-gaap	Interest Expense InterestExpense	342561	USD
CY2010	us-gaap	Interest Expense Debt InterestExpenseDebt	5800000	USD
CY2011	us-gaap	Interest Paid InterestPaid	54573	USD
CY2010	us-gaap	Interest Paid InterestPaid	1234142	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	67400	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7808553	USD
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	16660	USD
CY2010	us-gaap	Investment Income Interest InvestmentIncomeInterest	6955	USD
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	17808	USD
CY2011	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	800000	USD
CY2010	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1000000	USD
CY2010	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14864577	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2322906	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-3797573	USD
CY2010	us-gaap	Net Income Loss NetIncomeLoss	-34849277	USD
CY2011Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent		USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	749997	USD
CY2012Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	2500000	USD
CY2011Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1704108	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5781328	USD
CY2010	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21460452	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3720071	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1687521	USD
CY2010	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2756007	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-4920115	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-2679888	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-756543	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-213936	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-1269748	USD
CY2011Q1	us-gaap	Net Income Loss NetIncomeLoss	-2075657	USD
CY2011Q2	us-gaap	Net Income Loss NetIncomeLoss	-2437613	USD
CY2011Q3	us-gaap	Net Income Loss NetIncomeLoss	-33496	USD
CY2011Q4	us-gaap	Net Income Loss NetIncomeLoss	749193	USD
CY2011	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7928158	USD
CY2010	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11295720	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1541804	USD
CY2012	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2011	us-gaap	Operating Expenses OperatingExpenses	35992005	USD
CY2010	us-gaap	Operating Expenses OperatingExpenses	44547162	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	31442277	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-11725731	USD
CY2010	us-gaap	Operating Income Loss OperatingIncomeLoss	-23553557	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-6266390	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	56894	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53384	USD
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	39328	USD
CY2010	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	91355	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	47862	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1590696	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1458204	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1790377	USD
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1427113	USD
CY2011Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4539935	USD
CY2011Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3081320	USD
CY2011Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3021914	USD
CY2011Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1082562	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	809400	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	356900	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	846200	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	821600	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	797700	USD
CY2011Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent		USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	113130	USD
CY2011	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-239975	USD
CY2010	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	68824	USD
CY2012	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-194	USD
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4037548	USD
CY2010	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-34786936	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-6147965	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax		USD
CY2010	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-6483	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax		USD
CY2011	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	461073	USD
CY2010	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	5655865	USD
CY2012	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	303916	USD
CY2011Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	449709	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	579427	USD
CY2010	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit		USD
CY2012	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1330507	USD
CY2011	us-gaap	Paid In Kind Interest PaidInKindInterest		USD
CY2010	us-gaap	Paid In Kind Interest PaidInKindInterest	4653633	USD
CY2012	us-gaap	Paid In Kind Interest PaidInKindInterest	122342	USD
CY2010Q4	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	1000000	USD
CY2010Q2	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	175000	USD
CY2010Q3	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	260000	USD
CY2011	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		USD
CY2010	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		USD
CY2012	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	216460	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	71439	USD
CY2010	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	374581	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		USD
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	830585	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	547245	USD
CY2011Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5100000	USD
CY2011Q2	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	700000	USD
CY2010Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	17300000	USD
CY2010Q2	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2500000	USD
CY2010Q3	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	3900000	USD
CY2011Q2	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	6500000	USD
CY2011	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-74361	USD
CY2010	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-29184	USD
CY2012	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-32960	USD
CY2011	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit		USD
CY2011	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities		USD
CY2010	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	-100000	USD
CY2012	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	100000	USD
CY2011	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		USD
CY2010	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		USD
CY2012	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	67400	USD
CY2011	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		USD
CY2010	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	3130588	USD
CY2012	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		USD
CY2011	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	118309	USD
CY2010	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	56208	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	38984	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.86
CY2011	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	240111	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2401724	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2389156	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	788666	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	483976	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21219853	USD
CY2010	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20875536	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19509629	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4044636
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.86
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y7M6D
CY2011Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	100000	USD
CY2010Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	100000	USD
CY2011Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	100000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue		USD
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0079
CY2010	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	191495	USD
CY2012	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	57712	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-193689457	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-198609572	USD
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.032
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0118
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	34935	USD
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	29319	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	9067	USD
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	936533
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2273768
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	2565961	USD
CY2010	us-gaap	Share Based Compensation ShareBasedCompensation	2513159	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	1894099	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0	USD
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2011	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M24D
CY2010	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M24D
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0279
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0028
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0079
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.83
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.87
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	888035
CY2011	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y
CY2010	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y3M18D
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2009	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M6D
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.91
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1934566
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2722131
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	852139
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.17
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.88
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.86
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6292982
CY2010Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5339413
CY2009Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4913366
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6225612
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.74
CY2010Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.18
CY2009Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.88
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.52
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	5963894
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.55
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y3M18D
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue	2259625	USD
CY2010	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue	2300053	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue	2071649	USD
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.66
CY2010	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.56
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.24
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.07
CY2010	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.89
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.71
CY2010	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.5
CY2010	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	22316
CY2012	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	31474
CY2010	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	21830337	USD
CY2010Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	17000000	USD
CY2010	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-5457550	USD
CY2012	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	591039	USD
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.22
CY2010Q4	us-gaap	Share Price SharePrice	3.5
CY2010Q2	us-gaap	Share Price SharePrice	1.5
CY2010Q3	us-gaap	Share Price SharePrice	1.4
CY2011Q2	us-gaap	Share Price SharePrice	3.5
CY2011Q4	us-gaap	Short Term Borrowings ShortTermBorrowings		USD
CY2012Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1330507	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	15851806	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	12210705	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	3152399	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	11673840	USD
CY2010Q4	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	6700000
CY2010Q4	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	1900000
CY2010Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4945000
CY2010Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1666668
CY2010Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2785714
CY2011Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1857143
CY2011	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	44464
CY2010Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	4800000	USD
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5068728	USD
CY2010	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	19472024	USD
CY2011	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	118309	USD
CY2010	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	56208	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	38984	USD
CY2011Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	3021208	USD
CY2012Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	4114442	USD
CY2011	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	7144983	USD
CY2012	us-gaap	Use Of Estimates UseOfEstimates	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><em>Use of Estimates</em></strong></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with generally accepted accounting principles in the United States ("U.S. GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Our consolidated financial statements include significant estimates for the expected economic life and value of our intangible assets, and the amount of our net operating losses, our share-based compensation, our financial instruments, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates.</p> <!--EndFragment--></div> </div>
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	47331763
CY2010	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	32309621
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48323067

Files In Submission

Name	View Source	Status
0001144204-13-014894-index-headers.html	Edgar Link	pending
0001144204-13-014894-index.html	Edgar Link	pending
0001144204-13-014894.txt	Edgar Link	pending
0001144204-13-014894-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
image_004.jpg	Edgar Link	pending
pip-20121231.xml	Edgar Link	completed
pip-20121231.xsd	Edgar Link	pending
pip-20121231_cal.xml	Edgar Link	unprocessable
pip-20121231_def.xml	Edgar Link	unprocessable
pip-20121231_lab.xml	Edgar Link	unprocessable
pip-20121231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v334537_10k.htm	Edgar Link	pending
v334537_ex23.htm	Edgar Link	pending
v334537_ex31-1.htm	Edgar Link	pending
v334537_ex31-2.htm	Edgar Link	pending
v334537_ex32-1.htm	Edgar Link	pending
v334537_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALT
Altimmune, Inc. Stock $alt

2013 Q1 Form 10-K Financial Statement

#000114420413014894 Filed on March 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT Altimmune, Inc. Stock $alt

2013 Q1 Form 10-K Financial Statement

#000114420413014894 Filed on March 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT
Altimmune, Inc. Stock $alt